STOCK TITAN

Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company specializing in aortic disease, has announced the release date for its second quarter 2024 financial results. The results will be made public on Thursday, August 8, 2024, after market close. Following the release, the company will host a teleconference call and live webcast at 4:30 p.m. ET to discuss the results and conduct a Q&A session led by Pat Mackin, Chairman, President and CEO of Artivion.

Interested parties can access the live teleconference by dialing 201-689-8261 shortly before 4:30 p.m. ET. A replay will be available approximately one hour after the event. The live webcast and replay can be accessed through the Investors section of Artivion's website at www.artivion.com.

Artivion, Inc. (NYSE: AORT), un'azienda leader nella chirurgia cardiovascolare e vascolare specializzata nelle malattie aortiche, ha annunciato la data di rilascio dei suoi risultati finanziari del secondo trimestre 2024. I risultati saranno resi pubblici giovedì 8 agosto 2024, dopo la chiusura del mercato. Dopo il rilascio, l'azienda ospiterà una teleconferenza e un webcast dal vivo alle 16:30 ET per discutere i risultati e condurre una sessione di domande e risposte guidata da Pat Mackin, Presidente e CEO di Artivion.

Le parti interessate possono accedere alla teleconferenza in diretta componendo il numero 201-689-8261 poco prima delle 16:30 ET. Una registrazione sarà disponibile circa un'ora dopo l'evento. Il webcast live e la registrazione possono essere accessibili attraverso la sezione Investitori del sito web di Artivion su www.artivion.com.

Artivion, Inc. (NYSE: AORT), una empresa líder en cirugía cardíaca y vascular especializada en enfermedades aórticas, ha anunciado la fecha de publicación de sus resultados financieros del segundo trimestre de 2024. Los resultados se harán públicos el jueves 8 de agosto de 2024, después del cierre del mercado. Después de la publicación, la compañía llevará a cabo una llamada de teleconferencia y un webcast en vivo a las 4:30 p.m. ET para discutir los resultados y realizar una sesión de preguntas y respuestas dirigida por Pat Mackin, Presidente y CEO de Artivion.

Las partes interesadas pueden acceder a la teleconferencia en vivo marcando el 201-689-8261 poco antes de las 4:30 p.m. ET. Una repetición estará disponible aproximadamente una hora después del evento. El webcast en vivo y la repetición se pueden acceder a través de la sección de Inversores del sitio web de Artivion en www.artivion.com.

Artivion, Inc. (NYSE: AORT), 대동맥 질환을 전문으로 하는 심장 및 혈관 수술 분야의 선도 기업이 2024년 2분기 재무 결과 발표 일정을 발표했습니다. 결과는 2024년 8월 8일 목요일 시장 종료 후 공개됩니다. 발표 후, 회사는 동부 표준시 기준 오후 4시 30분에 결과를 논의하고 Pat Mackin, 회장, 사장 및 CEO가 이끄는 질의응답 세션을 진행하기 위한 전화 회의 및 라이브 웹캐스트를 주최합니다.

관심 있는 분들은 오후 4시 30분 이전에 201-689-8261로 전화하여 라이브 전화 회의에 참여할 수 있습니다. 이벤트 발생 약 1시간 후에 재생이 가능합니다. 라이브 웹캐스트와 재생은 Artivion의 웹사이트 www.artivion.com의 투자자 섹션을 통해 접근할 수 있습니다.

Artivion, Inc. (NYSE: AORT), une entreprise leader en chirurgie cardiaque et vasculaire spécialisée dans les maladies aortiques, a annoncé la date de publication de ses résultats financiers pour le deuxième trimestre 2024. Les résultats seront rendus public le jeudi 8 août 2024, après la fermeture du marché. À la suite de la publication, l'entreprise organisera une téléconférence et un webinaire en direct à 16h30 ET pour discuter des résultats et animer une session de questions-réponses dirigée par Pat Mackin, Président et CEO d'Artivion.

Les parties intéressées peuvent accéder à la téléconférence en direct en composant le 201-689-8261 peu avant 16h30 ET. Un enregistrement sera disponible environ une heure après l'événement. Le webinaire en direct et l'enregistrement peuvent être accédés via la section Investisseurs du site web d'Artivion à www.artivion.com.

Artivion, Inc. (NYSE: AORT), ein führendes Unternehmen in der Herz- und Gefäßchirurgie, das auf Aortenerkrankungen spezialisiert ist, hat das Datum der Veröffentlichung seiner Finanzergebnisse für das zweite Quartal 2024 bekannt gegeben. Die Ergebnisse werden am Donnerstag, den 8. August 2024, nach Börsenschluss veröffentlicht. Im Anschluss an die Veröffentlichung wird das Unternehmen um 16:30 Uhr ET eine Telefonkonferenz und einen Live-Webcast veranstalten, um die Ergebnisse zu besprechen und eine Fragen-und-Antworten-Runde unter der Leitung von Pat Mackin, Vorsitzender, Präsident und CEO von Artivion abzuhalten.

Interessierte Parteien können die Live-Telefonkonferenz anrufen, indem sie kurz vor 16:30 Uhr ET die Nummer 201-689-8261 anrufen. Eine Aufzeichnung wird etwa eine Stunde nach der Veranstaltung verfügbar sein. Der Live-Webcast und die Aufzeichnung können über den Investorenbereich der Website von Artivion unter www.artivion.com abgerufen werden.

Positive
  • None.
Negative
  • None.

ATLANTA, July 25, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2024 financial results will be released on Thursday, August 8, 2024 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question and answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of Artivion.

To listen to the live teleconference, please dial 201-689-8261 a few minutes prior to 4:30 p.m. ET. The teleconference replay will be available approximately one hour following the completion of the event and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The conference number for the replay is 13746922. 

The live webcast and replay can be accessed on the Investors section of the Artivion website at www.artivion.com and by selecting Webcasts & Presentations. In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investors section of the Artivion website.

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Contacts:

Artivion

Lance A. Berry

Executive Vice President &
Chief Financial Officer
Phone: 770-419-3355

Gilmartin Group LLC

Brian Johnston / Laine Morgan
Phone: 332-895-3222

investors@artivion.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-announces-release-date-and-teleconference-call-details-for-second-quarter-2024-financial-results-302207060.html

SOURCE Artivion, Inc.

FAQ

When will Artivion (AORT) release its Q2 2024 financial results?

Artivion (AORT) will release its second quarter 2024 financial results on Thursday, August 8, 2024, after the market closes.

What time is Artivion's (AORT) Q2 2024 earnings call scheduled for?

Artivion's (AORT) Q2 2024 earnings call is scheduled for 4:30 p.m. ET on Thursday, August 8, 2024.

How can I listen to Artivion's (AORT) Q2 2024 earnings call?

You can listen to Artivion's (AORT) Q2 2024 earnings call by dialing 201-689-8261 a few minutes before 4:30 p.m. ET on August 8, 2024, or by accessing the live webcast on the Investors section of Artivion's website.

Who will host Artivion's (AORT) Q2 2024 earnings call?

Artivion's (AORT) Q2 2024 earnings call will be hosted by Pat Mackin, Chairman, President and Chief Executive Officer of Artivion.

Artivion, Inc.

NYSE:AORT

AORT Rankings

AORT Latest News

AORT Stock Data

1.17B
36.71M
5.51%
87.55%
7.67%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
KENNESAW